• atbtherapeutics initiates agreement with iBio CDMO to manufacture game-changer atbodies to better treat cancer

    Tuesday December 1st 2020

  • Galapagos reports positive topline results with GLPG1205 in IPF patients in PINTA Proof-of-Concept trial

    Tuesday December 1st 2020

  • Newton Biocapital I invests in Perseus Proteomics Inc. in Japan to develop therapeutic antibodies for the treatment of blood cancers

    Tuesday December 1st 2020

  • Mithra's exclusivity on Estetrol applications extended to 2036 in Europe

    Tuesday December 1st 2020

  • flanders.bio job board increasingly popular

    Thursday November 26th 2020

  • Estetrol recognized as a "New Active Substance" by the European Medicines Agency (EMA)

    Wednesday November 25th 2020

  • Novalis Biotech announces first closing of its second healthcare fund

    Tuesday November 24th 2020

  • Selvita to acquire Fidelta from Galapagos

    Tuesday November 24th 2020

  • Your news here?

  • Qarad opent nieuw kantoor in VK

    Tuesday November 24th 2020

  • argenx enters into agreement to acquire Priority Review Voucher

    Monday November 23rd 2020

  • Aphea.Bio secures €14 million Series B financing to further develop its next generation agricultural biologicals

    Friday November 20th 2020


Strategic Partners